NEW YORK (GenomeWeb) – BioMérieux today reported organic sales growth of 4 percent for the fourth quarter, with full year 2015 organic sales up 7 percent.

The Marcy L'Etoile, France-based in vitro diagnostics firm said Q4 organic sales growth was slower than previous quarters due to unfavorable prior-year comparatives and a delayed start to the flu season. Sales for the three months ending Dec. 31, 2015 were €553.1 million ($599.6 million), a like-for-like change of 4 percent from €505.7 million in the year-ago period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Sponsored by

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.